Some of these fusions or mutations showed, to some degree, clinical significance, for instance, like ALK positive non-small cell lung cancer (NSCLC) [55], ROS1 positive NSCLC has more high risk of central nervous system metastasis [56]. Here, ALK is linked to non-small cell lung carcinoma.